A carregar...

In Vitro Multiexon Skipping by Antisense PMOs in Dystrophic Dog and Exon 7-Deleted DMD Patient

Antisense oligonucleotide induced exon skipping emerges as a promising therapeutic strategy for patients suffering from a devastating muscle disorder Duchenne muscular dystrophy (DMD). Systemic administration of antisense phosphorodiamidate morpholino oligomers (PMOs) targeting exons 6 and 8 in dyst...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Methods Mol Biol
Main Authors: Nakamura, Akinori, Aoki, Yoshitsugu, Tsoumpra, Maria, Yokota, Toshifumi, Takeda, Shin’ichi
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6557157/
https://ncbi.nlm.nih.gov/pubmed/30171540
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/978-1-4939-8651-4_9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!